The European urological device market will grow marginally through 2028. Revenue growth will be driven by ongoing product innovation and an increasing aging population and an associated rise in cases of urological diseases such as UI, stones, BPH, prostate and bladder cancer, and ED; however, limited capital equipment budgets among European health care facilities and prevailing preferences for established treatment methods will hinder the adoption of newer, premium-priced technology to some degree, hampering overall market growth.
This Medtech 360 Report provides high-level market metrics for urological devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
- Urological Devices - Market Insights - Europe (Supplemental)
Author(s): Sumit Jain, MS Pharm
Sumit Jain is an analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, focusing on diagnostic imaging capital equipment and healthcare IT markets. Sumit holds a Bachelor's degree in Pharmacy from the Rajiv Gandhi Technical University, Bhopal, and a Master's degree in Pharmacoinformatics from the National Institute of Pharmaceutical Education and Research, Mohali.